Funding process
 | This section is empty. You can help by adding to it. (January 2018) |
In the United States, the National Institutes of Health (NIH) are the primary government agency responsible for biomedical and public health research. They award NIH grants through 24 grant-awarding institutes and centers. [1]
The NIH supports $31 billion in research annually, given to more than 300,000 researchers at more than 2,500 institutions for research into a variety of conditions. [2] Each institute of the NIH has separate appropriations from Congress determined on an annual basis. Percentages of grant applications funded vary by institute, from 8% (National Institute of Nursing Research) to 29.6% (National Institute of General Medical Sciences), with an overall average of 18%. Funding percentages have dropped from over 30% in the early 2000s, mainly due to an increase in applications, rather than a decrease in funds available. In 1998, 24,100 applications were received, and 7,500 were funded with a total of $1.9 billion. By 2005, the number of applications had grown to 43,000, of which 9,600 were funded with a total of $3.4 billion. In 2015, 52,000 applications were submitted and 9,500 were funded with $4.3 billion. [3] Grants are assessed based on their significance, innovation, and approach.
The major grant awards of the NIH are divided into Research Grants (R series), Career Development Awards (K series), Research Training and Fellowships (T & F series), Program Project/Center Grants (P series), and miscellaneous programs. [4]
There are various requirements for grants. Some grants are specified for "new investigators", which is defined as someone who has not received a prior NIH grant other than a career award or specific small grants (R15, R21, R56, etc.). An "early stage investigator" is someone who has received their PhD or MD or has finished residency within the past 10 years. [5]
From 2010 to 2016, NIH funded research that led to the development and approval of 210 new drugs. 84 of these were "first-in-class" drugs, meaning they work through previously unknown mechanisms. About 90% of the research published from the funded grants related to the discovery and characterization of these pathways, rather than the development of the drug itself. [6]
A study on the value of public research funding found that 30% of NIH grants led to research being published that was cited in a patent application, and that for every $100 million funded by the NIH, 23 patents were submitted. [7]
NIH numbers the types of applications:
Applications are reviewed by a Scientific Review Group made up of volunteer subject matter experts, generally professors in the relevant fields, and by a National Advisory Council made up of federal employees. Grants are scored from 1 to 9, with 1 being the highest score. Members of the committees are listed publicly. [9]
| | This section is empty. You can help by adding to it. (January 2018) |
The most common research grant mechanism is the R01. It is the oldest funding mechanism of the NIH. R01s are generally awarded for 3–5 years, and are used to support a "discrete, specified, circumscribed research project". R01s can be renewed by competitive application. The application cycle has 3 sets of application dates each year. Standard due dates for new grant applications are February, June, and October 5, and for renewal, resubmission, and revision grant applications are March, July, and November 5. AIDs-related grants have separate due dates. All grant-awarding institutes and centers award R01s. [10] Applications for R01s are complex and are typically over 100 pages by submission.
In financial year 2016, the NIH received 26,187 applications for new R01 grants. 17.3% were funded, for a total of $2.2 billion. [11] The average annual budget was $460,000. [12]
Other research grant programs include:
The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.
The National Institute of General Medical Sciences (NIGMS) supports basic research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS-funded scientists investigate how living systems work at a range of levels, from molecules and cells to tissues and organs, in research organisms, humans, and populations. Additionally, to ensure the vitality and continued productivity of the research enterprise, NIGMS provides leadership in training the next generation of scientists, in enhancing the diversity of the scientific workforce, and in developing research capacity throughout the country.
The National Institute of Neurological Disorders and Stroke (NINDS) is a part of the U.S. National Institutes of Health (NIH). It conducts and funds research on brain and nervous system disorders and has a budget of just over US$2.03 billion. The mission of NINDS is "to reduce the burden of neurological disease—a burden borne by every age group, every segment of society, and people all over the world". NINDS has established two major branches for research: an extramural branch that funds studies outside the NIH, and an intramural branch that funds research inside the NIH. Most of NINDS' budget goes to fund extramural research. NINDS' basic science research focuses on studies of the fundamental biology of the brain and nervous system, genetics, neurodegeneration, learning and memory, motor control, brain repair, and synapses. NINDS also funds clinical research related to diseases and disorders of the brain and nervous system, e.g. AIDS, Alzheimer's disease, epilepsy, muscular dystrophy, multiple sclerosis, Parkinson's disease, spinal cord injury, stroke, and traumatic brain injury.
The National Center for Complementary and Integrative Health (NCCIH) is a United States government agency which explores complementary and alternative medicine (CAM). It was initially created in 1991 as the Office of Alternative Medicine (OAM), and renamed the National Center for Complementary and Alternative Medicine (NCCAM) before receiving its current name in 2014. NCCIH is one of the 27 institutes and centers that make up the National Institutes of Health (NIH) within the United States Department of Health and Human Services.
The National Institute of Mental Health (NIMH) is one of 27 institutes and centers that make up the National Institutes of Health (NIH). The NIH, in turn, is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).
The National Heart, Lung, and Blood Institute (NHLBI) is the third largest Institute of the National Institutes of Health, located in Bethesda, Maryland, United States. It is tasked with allocating about $3.6 billion in FY 2020 in tax revenue to advancing the understanding of the following issues: development and progression of disease, diagnosis of disease, treatment of disease, disease prevention, reduction of health care disparities within the American population, and advancing the effectiveness of the US medical system. NHLBI's Director is Gary H. Gibbons (2012–present).
The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.
A grant is a fund given by a person or organization, often a public body, charitable foundation, a specialised grant-making institution, or in some cases a business with a corporate social responsibility mission, to an individual or another entity, usually, a non-profit organisation, sometimes a business or a local government body, for a specific purpose linked to public benefit. Unlike loans, grants are not intended to be paid back. Examples include student grants, research grants, the Sovereign Grant paid by the UK Treasury to the monarch, and some European Regional Development Fund payments in the European Union.
Medical research, also known as health research, refers to the process of using scientific methods with the aim to produce knowledge about human diseases, the prevention and treatment of illness, and the promotion of health.
The Medical Scientist Training Programs (MSTPs) are dual-degree training programs that streamline the education towards both clinical and research doctoral degrees. MSTPs are offered by some United States medical schools, who are awarded financial support from the National Institute of General Medical Sciences, a branch of the National Institutes of Health (NIH). The goal of these training programs is to produce physician scientists who can translate laboratory discoveries into effective treatments for patients.
The National Multiple Sclerosis Society (NMSS) is an American nonprofit organization founded in 1946. It is an organization dedicated to supporting individuals affected by multiple sclerosis (MS) and funding research to find a cure for the disease. They provide resources, support services, advocacy efforts, and educational programs to improve the lives of people with MS and their families.
In many countries, the term principal investigator (PI) refers to the holder of an independent grant and the lead researcher for the grant project, usually in the sciences, such as a laboratory study or a clinical trial. The phrase is also often used as a synonym for "head of the laboratory" or "research group leader". While the expression is common in the sciences, it is used widely for the person or persons who make final decisions and supervise funding and expenditures on a given research project.
The Ruth L. Kirschstein National Research Service Awards are a family of grants provided by the United States National Institutes of Health for training researchers in the behavioral sciences and health sciences. They are a highly selective and very prestigious source of funding for doctoral and postdoctoral trainees. The grants are awarded based on lengthy proposals submitted by applicants in which original experimental plans are described. The proposals are evaluated and given an impact score reflecting scientific merit by a study section at the Center for Scientific Review at the NIH. Only applications with very good impact scores are funded, based on budget cutoffs determined by each individual institute. US citizenship or permanent residency is required. The NIH awarded $77,000,000 in individual grants and over $600,000,000 in institutional training grants in fiscal year 2005.
The National Center for Research Resources (NCRR) was a center within the National Institutes of Health, a United States government agency. NCRR provided funding to laboratory scientists and researchers for facilities and tools in the goal of curing and treating diseases.
Joe G. N. "Skip" Garcia is an American pulmonary scientist, physician and academician.
Ruth Lillian Kirschstein was an American pathologist and science administrator at the National Institutes of Health (NIH). Kirschstein served as director of the National Institute of General Medical Sciences, deputy director of NIH in the 1990s, and acting director of the NIH in 1993 and 2000-2002.
A physician-scientist or clinician-scientist is a physician who divides their professional time between direct clinical practice with patients and scientific research. Physician-scientists traditionally hold both a medical degree and a doctor of philosophy, also known as an MD-PhD. Compared to other clinicians, physician-scientists invest significant time and professional effort in scientific research, with ratios of research to clinical time ranging from 50/50 to 80/20.
Chan Zuckerberg Biohub, or simply Biohub, is a nonprofit research organization. In addition to supporting and conducting original research, CZ Biohub acts as a hub and fosters science collaboration between UC Berkeley, UC San Francisco (UCSF) and Stanford. The Biohub is funded by a $600 million contribution from Facebook CEO and founder Mark Zuckerberg and his wife Priscilla Chan. It was co-led by Stephen Quake and Joseph DeRisi from its inception in 2016 until 2022, when Quake left to become president of the Biohub Network. Sandra Schmid joined as Chief Scientific Officer in 2020.
John X. J. Zhang is a tenured professor at Thayer School of Engineering of Dartmouth College, and an investigator in the Dartmouth-Hitchcock Medical Center. Before joining Dartmouth, he was an associate professor with tenure in the Department of Biomedical Engineering at the University of Texas(UT Austin). He received his Ph.D. in electrical engineering from Stanford University, California in 2004, and was a research scientist in systems biology at the Massachusetts Institute of Technology (MIT) before joining the faculty at UT Austin in 2005. Zhang is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE), and a recipient of the 2016 NIH Director's Transformative Research Award.